IFRX has information throughout their website over their commitment to expansion, development, and leading the industry. While this is great when attempting to identify investors, and maybe some potentially great employee talent, when numerous pages overnight are drastically removed, altered, deleted, or simply emptied, investors are quick to ask questions. Today, that is exactly what IFRX did, but why?
As we begin looking at Chapter 3, we are immediately hit with the Structure-Conduct-Performance (SCP) Concept. While the SCP is more of a large-scale economies approach to understanding an organizations activities. Now, Biotech is far from ever being called ‘small,’ however IFRX is focusing on a very small segment of the industry. Have they found some backers to reinvest? are they looking at a change in philosophy? are they having fiscal difficulties? I predict major changes within the next month, as it is only a matter of time before they go after a PR move; as long as they don’t do PTN’s method, then all will be good in the end (I have faith you can look up what PTN did today that interfered with their 300% stock price potential). Good luck!
IFRX 